Measurement of Renal Function With Iohexol in Subjects Ingesting Carnitine
Information source: Montefiore Medical Center
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Carnitine Ingestion
Intervention: Carnitine (Dietary Supplement)
Phase: N/A
Status: Withdrawn
Sponsored by: Montefiore Medical Center
Summary
The investigators will measure renal function in subjects ingesting carnitine to determine
if the product alters renal function.
Clinical Details
Official title: Measurement of Glomerular Filtration Rate (GFR) Using Iohexol in Healthy Subjects Taking Creatinine Supplements
Study design: Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention
Primary outcome: Iohexol clearance
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- carnitine ingestion
Exclusion Criteria:
- renal disease
Locations and Contacts
Montefiore Medical Center, Bronx, New York 10467, United States
Additional Information
Starting date: May 2010
Last updated: July 11, 2011
|